Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BIONTECH : Jefferies sticks Neutral

11/22/2021 | 02:29am EST

Initially Neutral on the company, Jefferies's analyst Akash Tewari maintained his recommendation. The target price remains unchanged at USD 230.


© MarketScreener with dpa-AFX Analyser 2021
All news about BIONTECH SE
01/18Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud..
MT
01/18Morgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/14Omicron leaves Germany on brink of recession as growth dips
AQ
01/14German economy short of pre-pandemic level despite 2.7% growth in 2021
RE
01/13European ADRs Move Higher in Thursday Trading
MT
01/13Acuitas Therapeutics Names Miranda Lam as
AQ
01/13Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVN..
AQ
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 454 M 19 783 M 19 783 M
Net income 2021 9 220 M 10 450 M 10 450 M
Net cash 2021 8 918 M 10 108 M 10 108 M
P/E ratio 2021 4,07x
Yield 2021 -
Capitalization 36 079 M 40 873 M 40 895 M
EV / Sales 2021 1,56x
EV / Sales 2022 1,06x
Nbr of Employees 2 800
Free-Float -
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 149,38 €
Average target price 263,77 €
Spread / Average Target 76,6%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE-34.36%40 873
GILEAD SCIENCES, INC.-3.00%88 346
REGENERON PHARMACEUTICALS-3.21%63 906
VERTEX PHARMACEUTICALS5.22%58 750
WUXI APPTEC CO., LTD.-0.66%54 178
BEIGENE, LTD.-11.55%24 621